The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.
By Michael Ollove, Stateline
As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to cushion the financial pain for patients who need medicine that can cost up to hundreds of…
By Richard Knox, NPR
A growing number of people who got infected in the 1960s through the 1990s have now "used up" the infection's latency period, notes Dr. Camilla Graham of Beth Israel Deaconess Hospital in Boston, "which is why we're now seeing this…
Should doctors be paid by pharmaceutical companies to promote their drugs?…
Drug companies and the State of Maine battle over the importation of prescription drugs.
NewsHour special correspondent Jeffrey Kaye reports on China's health care reform.
A massive egg recall over fears of a salmonella outbreak raises new questions on whether the Food and Drug Administration can handle its regulatory role. Betty Ann Bowser has more.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.